Clinical

Site Selection and Feasibility Access

Building the foundation for a successful trial

The careful selection and evaluation of investigative sites is critical for the success of clinical trials—with potential impacts to budgetary and timing requirements as well as the quality of clinical data generated.

Alira Health works closely with clients to efficiently develop detailed, indication-focused site feasibility tools. These tools are designed to ensure a strong rate of site qualification, increasing the probability of sites that meet expectations for approval.

Leveraging a strong global network of clinical sites

Over the last two decades, Alira Health has developed deep industry experience and created long-standing relationships with hundreds of study coordinators and investigators around the world.

Our extensive pharmaceutical and medical device clinical research database allows us to target reliable, relevant trial sites known for solid accrual potential and good data quality in the relevant study population.

Why choose Alira Health?

With Alira Health industry leading CRO as your partner, you will benefit from:

  • Exceptional customer service and site relations
  • In-depth expertise across the entire clinical trial process
  • Flexible and tailored service delivered by multidisciplinary and global teams
  • Frequent, transparent, and professional communication
  • Guarantee we will lead your study efficiently, safely, and successfully

Related News

Clinical
News June 8, 2021
Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT
We have acquired CROS NT, a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality,(...)
Clinical
Multimedia June 4, 2021
Managing Relationships Between CROs and Clinical Trial Sites
Join us in this special episode of Alira Health’s Transformation Talks with a full cast of Alira Health experts.
Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)
Clinical Regulatory
News January 7, 2021
Alira Health Adds CMC Services through Acquisition of Chamow & Associates
We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)
Clinical
Publications September 4, 2020
Clinical Trial Management – The Dharmic Approach
In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance (and certified yoga instructor), writes about the connections between yoga, dharma, and(...)
Clinical
Publications July 1, 2020
Clinical Trials Trends: Remote Monitoring
The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the concept of remote monitoring existed before the pandemic, with(...)
Clinical
Publications May 6, 2020
What You Should Know before Selecting a CRO
When running a clinical trial, it is important to choose the right CRO. This choice impacts the quality and experience of conducting the study.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.